NCT06388642 Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients Status COMPLETED Phase PHASE1/PHASE2
NCT05883748 HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP Status ENROLLING_BY_INVITATION Phase PHASE2/PHASE3
NCT05780840 Protection Against Visible Light by Dihydroxyacetone in Erythropoietic Protoporphyria Status UNKNOWN Phase NA
NCT05308472 Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP Status COMPLETED Phase PHASE2
NCT04578496 A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP) Status COMPLETED Phase PHASE3
NCT03682731 Light Exposure Patterns and Symptoms Among Patients With Erythropoietic Protoporphyria Status COMPLETED Phase N/A
NCT01688895 Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact Status COMPLETED Phase N/A
NCT01605136 Phase III Confirmatory Study in Erythropoietic Protoporphyria Status COMPLETED Phase PHASE3
NCT01097044 Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP) Status COMPLETED Phase PHASE2
NCT00979745 Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP) Status COMPLETED Phase PHASE3
NCT00206869 Does Exercise and Heat Increase the Lightsensibility in Patients With Erythropoietic Protoporphyria Status UNKNOWN Phase NA
NCT00004940 Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria Status COMPLETED Phase PHASE3
NCT00004831 Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria Status COMPLETED Phase NA